Subscribe To
Innoviva: a lot of moving parts
Innoviva, Inc. is a biopharma company focused on the development and commercialization of pharmaceutical...
October 9, 2023, 1:48 pm
How ozempic accidentally made novo nordisk a $400b company
pharmaceutical giant, Novo Nordisk, is now Europe's most valuable company, worth more than its home cou...
October 9, 2023, 12:30 pm
Bristol myers squibb to buy cancer drugmaker mirati therapeutics in up to $5.8b deal
Bristol Myers Squibb will buy Mirati Therapeutics in a deal worth up to $5.8 billion, or $58 per share, the bio...
October 9, 2023, 11:40 am
Are medical stocks lagging cabaletta bio (caba) this year?
Here is how Cabaletta Bio, Inc. (CABA) and KalVista pharmaceuticals, Inc. (KALV) have performed compare...
October 9, 2023, 11:17 am
Plus therapeutics to participate in the jones trading healthcare summit and thinkequity conference in october
AUSTIN, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage ...
October 9, 2023, 11:00 am
Cramer's mad dash: vertex pharmaceuticals
CNBC's Jim Cramer delivers his daily Mad Dash....
October 9, 2023, 10:58 am
Cramer says vertex has a drug that may address the 'largest market opportunity in the world'
CNBC's Jim Cramer said investors keep an eye on Vertex pharmaceuticals (VRTX) as the company develops a...
October 9, 2023, 10:18 am
Terns pharmaceuticals: business model does not impress
Terns pharmaceuticals stock is down 15% in the past 10 months, despite bullish articles following a bea...
October 9, 2023, 9:19 am
These israeli pharmaceutical stocks are down in the wake of hamas attack
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on...
October 9, 2023, 8:53 am
Us fda declines approval for expanded use of alnylam's heart-disease drug
The U.S. Food and Drug Administration has declined to approve the expanded use of Alnylam pharmaceutical...
October 9, 2023, 7:44 am
Alnylam to scrap snda for patisiran after receiving fda complete response letter
Alnylam pharmaceuticals Inc. ALNY, -1.00% said Monday it would no longer pursue its supplemental new dr...
October 9, 2023, 7:43 am
Gsk reportedly set to shake up r&d opertion
GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...
October 9, 2023, 2:14 am
Infinity alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against infinity pharmaceuticals, inc. and encourages investors to contact the firm
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that ...
October 9, 2023, 1:00 am
Bristol myers squibb to acquire mirati therapeutics in deal worth up to $5.8 billion
The deal expands the pharmaceutical company's portfolio of cancer drugs....
October 8, 2023, 6:12 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm